Orphan Therapeutics Accelerator Announces Foundational Partnerships
Founding Members Chiesi, BIAL Lead Initial Funding;
Landmark Bio, Uncommon Cures Join Clinical Development Network;
DVLP Medicines, Vibe Bio to Provide Integrated AI-based Solutions
The Future of Aging, AI, and Robotics with CEO of Insilico Medicine
Insilico Medicine’s mission is to extend healthy productive longevity by transforming drug discovery and development with generative artificial intelligence.
